Karen Firestone - 16 Mar 2023 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role: Director
Signature: /s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol: AMLX
Transactions as of: 16 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 20 Mar 2023, 20:09:07 UTC
Next filing: 12 Jun 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney